Novo Integrated Sciences Stock Net Income
| NVOS Stock | USD 0 0.0004 12.90% |
As of the 29th of January, Novo Integrated secures the Risk Adjusted Performance of 0.1313, mean deviation of 45.09, and Downside Deviation of 45.8. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novo Integrated Sciences, as well as the relationship between them. Please verify Novo Integrated Sciences jensen alpha and semi variance to decide if Novo Integrated Sciences is priced some-what accurately, providing market reflects its recent price of 0.0035000001 per share. As Novo Integrated Sciences appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.
Novo Integrated Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.2236 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -11.9 M | -11.3 M | |
| Net Loss | -11.9 M | -11.3 M | |
| Net Loss | -4 M | -3.8 M | |
| Net Loss | (0.66) | (0.70) | |
| Net Income Per E B T | 1.15 | 1.12 |
Novo | Net Income | Build AI portfolio with Novo Stock |
Latest Novo Integrated's Net Income Growth Pattern
Below is the plot of the Net Income of Novo Integrated Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Novo Integrated Sciences financial statement analysis. It represents the amount of money remaining after all of Novo Integrated Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Novo Integrated's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novo Integrated's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (13.27 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Novo Net Income Regression Statistics
| Arithmetic Mean | (7,112,228) | |
| Coefficient Of Variation | (130.45) | |
| Mean Deviation | 7,546,958 | |
| Median | (2,108,012) | |
| Standard Deviation | 9,277,672 | |
| Sample Variance | 86.1T | |
| Range | 32.9M | |
| R-Value | (0.72) | |
| Mean Square Error | 43.9T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (1,327,210) | |
| Total Sum of Squares | 1377.2T |
Novo Net Income History
Other Fundumenentals of Novo Integrated Sciences
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Novo Integrated Net Income component correlations
Novo Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Novo Integrated is extremely important. It helps to project a fair market value of Novo Stock properly, considering its historical fundamentals such as Net Income. Since Novo Integrated's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Novo Integrated's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Novo Integrated's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Providers & Services market expansion? Will Novo introduce new products? Factors like these will boost the valuation of Novo Integrated. Anticipated expansion of Novo directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Novo Integrated listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.33) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
Investors evaluate Novo Integrated Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Novo Integrated's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Novo Integrated's market price to deviate significantly from intrinsic value.
It's important to distinguish between Novo Integrated's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Novo Integrated should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Novo Integrated's market price signifies the transaction level at which participants voluntarily complete trades.
Novo Integrated 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novo Integrated's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novo Integrated.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Novo Integrated on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Novo Integrated Sciences or generate 0.0% return on investment in Novo Integrated over 90 days. Novo Integrated is related to or competes with Sonendo. Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related p... More
Novo Integrated Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novo Integrated's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novo Integrated Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 45.8 | |||
| Information Ratio | 0.1644 | |||
| Maximum Drawdown | 980.77 | |||
| Value At Risk | (32.00) | |||
| Potential Upside | 90.91 |
Novo Integrated Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novo Integrated's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novo Integrated's standard deviation. In reality, there are many statistical measures that can use Novo Integrated historical prices to predict the future Novo Integrated's volatility.| Risk Adjusted Performance | 0.1313 | |||
| Jensen Alpha | 20.57 | |||
| Total Risk Alpha | 9.61 | |||
| Sortino Ratio | 0.4498 | |||
| Treynor Ratio | 14.8 |
Novo Integrated January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1313 | |||
| Market Risk Adjusted Performance | 14.81 | |||
| Mean Deviation | 45.09 | |||
| Semi Deviation | 18.92 | |||
| Downside Deviation | 45.8 | |||
| Coefficient Of Variation | 606.16 | |||
| Standard Deviation | 125.32 | |||
| Variance | 15706.2 | |||
| Information Ratio | 0.1644 | |||
| Jensen Alpha | 20.57 | |||
| Total Risk Alpha | 9.61 | |||
| Sortino Ratio | 0.4498 | |||
| Treynor Ratio | 14.8 | |||
| Maximum Drawdown | 980.77 | |||
| Value At Risk | (32.00) | |||
| Potential Upside | 90.91 | |||
| Downside Variance | 2097.55 | |||
| Semi Variance | 357.95 | |||
| Expected Short fall | (113.50) | |||
| Skewness | 6.05 | |||
| Kurtosis | 39.89 |
Novo Integrated Sciences Backtested Returns
Novo Integrated is out of control given 3 months investment horizon. Novo Integrated Sciences has Sharpe Ratio of 0.17, which conveys that the firm had a 0.17 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 22.13% are justified by taking the suggested risk. Use Novo Integrated Sciences Downside Deviation of 45.8, mean deviation of 45.09, and Risk Adjusted Performance of 0.1313 to evaluate company specific risk that cannot be diversified away. Novo Integrated holds a performance score of 13 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 1.4, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Novo Integrated will likely underperform. Use Novo Integrated Sciences semi variance, as well as the relationship between the rate of daily change and relative strength index , to analyze future returns on Novo Integrated Sciences.
Auto-correlation | -0.66 |
Very good reverse predictability
Novo Integrated Sciences has very good reverse predictability. Overlapping area represents the amount of predictability between Novo Integrated time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novo Integrated Sciences price movement. The serial correlation of -0.66 indicates that around 66.0% of current Novo Integrated price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.66 | |
| Spearman Rank Test | -0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Novo Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Novo Integrated Sciences reported net income of (13.27 Million). This is 103.89% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 102.32% higher than that of the company.
Novo Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novo Integrated's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Novo Integrated could also be used in its relative valuation, which is a method of valuing Novo Integrated by comparing valuation metrics of similar companies.Novo Integrated is currently under evaluation in net income category among its peers.
Novo Integrated Institutional Holders
Institutional Holdings refers to the ownership stake in Novo Integrated that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Novo Integrated's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Novo Integrated's value.| Shares | Advisor Group Holdings, Inc. | 2025-03-31 | 0.0 |
Novo Fundamentals
| Return On Equity | -0.82 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (1.22) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 3.02 M | ||||
| Shares Outstanding | 19.73 M | ||||
| Shares Owned By Insiders | 6.58 % | ||||
| Number Of Shares Shorted | 274.86 K | ||||
| Price To Book | 0.01 X | ||||
| Price To Sales | 0 X | ||||
| Revenue | 13.29 M | ||||
| Gross Profit | 5.74 M | ||||
| EBITDA | (10.08 M) | ||||
| Net Income | (13.27 M) | ||||
| Cash And Equivalents | 12.68 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 4.71 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.78 X | ||||
| Cash Flow From Operations | (2.24 M) | ||||
| Short Ratio | 1.13 X | ||||
| Earnings Per Share | (1.33) X | ||||
| Number Of Employees | 115 | ||||
| Beta | 1.16 | ||||
| Market Capitalization | 61.16 K | ||||
| Total Asset | 32.14 M | ||||
| Retained Earnings | (83.2 M) | ||||
| Working Capital | (3.52 M) | ||||
| Net Asset | 32.14 M |
About Novo Integrated Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novo Integrated Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novo Integrated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novo Integrated Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Novo Stock Analysis
When running Novo Integrated's price analysis, check to measure Novo Integrated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Integrated is operating at the current time. Most of Novo Integrated's value examination focuses on studying past and present price action to predict the probability of Novo Integrated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Integrated's price. Additionally, you may evaluate how the addition of Novo Integrated to your portfolios can decrease your overall portfolio volatility.